Role of targeted therapy in the treatment of HER-2-positive breast cancer brain metastases

Role of targeted therapy in the treatment of HER-2-positive breast cancer brain metastases

Brain metastases are detectable in 25–35 % of patients with progressive HER-2-positve breast cancer. Even after spreading metastases into the brain, chemotherapy in combination with anti-HER- 2 therapy improves survival due to better control of the systemic disease. The paper presents the results of...

Full description

Saved in:
Bibliographic Details
Main Authors: G. A. Dashyan, V. F. Semiglazov, P. V. Krivorot’ko, T. Yu. Semiglazova, E. E. Topuzov, R. M. Paltuev, K. Yu. Zernov, V. S. Apollonova, S. S. Ereshchenko, A. V. Petrova, E. K. Zhil’tsova, O. A. Ivanova
Format: Article
Language:Russian
Published: ABV-press 2016-06-01
Series:Опухоли женской репродуктивной системы
Subjects:
her-2-positve breast cancer
central nervous system metastases
t-dm1
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/475
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items